Clinical Trial

Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients

Study acronym: ACUPOX
Recruiting
View on ClinicalTrials.gov →
Summary
ACUPOX is a multicenter, open label, 2-cohort based phase II clinical study evaluating the interest of a standardized protocol of verum acupuncture in treatment of Oxaliplatin-induced peripheral neuropathy in patients with gastro-intestinal solid tumors who discontinued oxaliplatin-containing chemotherapy.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-04-28; most recent amendment 2025-07-22.
Status change: Not Yet Recruiting → Recruiting 2024-01-02
Trial Details
NCT Number NCT05850130
Lead Sponsor GERCOR - Multidisciplinary Oncology Cooperative Group
Conditions Colorectal Cancer, Liver Cancer, Gastric Cancer, Pancreas Cancer, Esophagus Cancer
Enrollment 182 participants
Start Date 2023-11-22
Primary Completion 2026-10 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-07-23